Staphylococcus aureus can cause localized infections such as abscesses and pneumonia, as well as systemic infections such as bacteremia and sepsis. Especially, methicillin-resistant S. aureus often presents multidrug resistance, which becomes a major clinical challenge. One of the most common reasons for methicillin-resistant S. aureus antibiotic resistance is the presence of biofilms. Natural antimicrobial peptides derived from different species have shown effectiveness in combating S. aureus biofilms. In this review, we summarize the inhibitory activity of antimicrobial peptides against S. aureus planktonic cells and biofilms. We also summarize the possible inhibitory mechanisms, involving cell adhesion inhibition, membrane fracture, biofilm disruption and DNA disruption. We believe this can provide the basis for further research against S. aureus biofilm-associated infections.
金黄色葡萄球菌可引起脓肿和肺炎等局部感染,以及菌血症和败血症等全身感染。尤其是耐甲氧西林的金黄色葡萄球菌往往具有多重耐药性,成为临床上的一大难题。耐甲氧西林金黄色葡萄球菌产生抗生素耐药性的最常见原因之一是生物膜的存在。从不同物种中提取的天然抗菌肽已显示出对抗金黄色葡萄球菌生物膜的有效性。在这篇综述中,我们总结了抗菌肽对金黄色葡萄球菌浮游细胞和生物膜的抑制活性。我们还总结了可能的抑制机制,包括细胞粘附抑制、膜断裂、生物膜破坏和 DNA 破坏。我们相信这能为进一步研究金黄色葡萄球菌生物膜相关感染提供基础。
{"title":"Anti-<i>Staphylococcus aureus</i> effects of natural antimicrobial peptides and the underlying mechanisms.","authors":"Xueqi Chen, Jiuli Yang, Chang Qu, Qian Zhang, Shujuan Sun, Lihong Liu","doi":"10.2217/fmb-2023-0168","DOIUrl":"10.2217/fmb-2023-0168","url":null,"abstract":"<p><p><i>Staphylococcus aureus</i> can cause localized infections such as abscesses and pneumonia, as well as systemic infections such as bacteremia and sepsis. Especially, methicillin-resistant <i>S. aureus</i> often presents multidrug resistance, which becomes a major clinical challenge. One of the most common reasons for methicillin-resistant <i>S. aureus</i> antibiotic resistance is the presence of biofilms. Natural antimicrobial peptides derived from different species have shown effectiveness in combating <i>S. aureus</i> biofilms. In this review, we summarize the inhibitory activity of antimicrobial peptides against <i>S. aureus</i> planktonic cells and biofilms. We also summarize the possible inhibitory mechanisms, involving cell adhesion inhibition, membrane fracture, biofilm disruption and DNA disruption. We believe this can provide the basis for further research against <i>S. aureus</i> biofilm-associated infections.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"355-372"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140027891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-02-21DOI: 10.2217/fmb-2023-0189
Aakriti Garg, Sonali Karhana, Mohd A Khan
Helicobacter pylori infection is linked to gastritis, ulcers and gastric cancer. Nanomedicine offers a promising solution by utilizing nanoparticles for precise drug delivery, countering antibiotic resistance and delivery issues. Nanocarriers such as liposomes and nanoparticles enhance drug stability and circulation, targeting infection sites through gastric mucosa characteristics. Challenges include biocompatibility, stability, scalability and personalized therapies. Despite obstacles, nanomedicine's potential for reshaping H. pylori eradication is significant and showcased in this review focusing on benefits, limitations and future prospects of nanomedicine-based strategies.
{"title":"Nanomedicine for the eradication of <i>Helicobacter pylori</i>: recent advances, challenges and future perspective.","authors":"Aakriti Garg, Sonali Karhana, Mohd A Khan","doi":"10.2217/fmb-2023-0189","DOIUrl":"10.2217/fmb-2023-0189","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> infection is linked to gastritis, ulcers and gastric cancer. Nanomedicine offers a promising solution by utilizing nanoparticles for precise drug delivery, countering antibiotic resistance and delivery issues. Nanocarriers such as liposomes and nanoparticles enhance drug stability and circulation, targeting infection sites through gastric mucosa characteristics. Challenges include biocompatibility, stability, scalability and personalized therapies. Despite obstacles, nanomedicine's potential for reshaping <i>H. pylori</i> eradication is significant and showcased in this review focusing on benefits, limitations and future prospects of nanomedicine-based strategies.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"431-447"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139912383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-01-31DOI: 10.2217/fmb-2023-0190
Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza
Aim: The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. Methods: Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. Results: Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. Conclusion: Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications.
{"title":"Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis.","authors":"Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza","doi":"10.2217/fmb-2023-0190","DOIUrl":"10.2217/fmb-2023-0190","url":null,"abstract":"<p><p><b>Aim:</b> The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. <b>Methods:</b> Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. <b>Results:</b> Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. <b>Conclusion:</b> Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"297-305"},"PeriodicalIF":2.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To investigate the effects of Ferrostatin-1 (Fer-1) on improving the prognosis of liver transplant recipients with steatotic liver grafts and regulating gut microbiota in rats. Methods: We obtained steatotic liver grafts and established a liver transplantation model. Recipients were divided into sham, liver transplantation and Fer-1 treatment groups, which were assessed 1 and 7 days after surgery (n = 6). Results & conclusion: Fer-1 promotes recovery of the histological structure and function of steatotic liver grafts and the intestinal tract, and improves inflammatory responses of recipients following liver transplantation. Fer-1 reduces gut microbiota pathogenicity, and lowers iron absorption and improves fat metabolism of recipients, thereby protecting steatotic liver grafts.
{"title":"Ferrostatin-1 improves prognosis and regulates gut microbiota of steatotic liver transplantation recipients in rats.","authors":"Mengshu Yuan, Yuxin Wang, Xiaorong Tian, Weiping Zheng, Huaiwen Zuo, Xinru Zhang, Hongli Song","doi":"10.2217/fmb-2023-0133","DOIUrl":"10.2217/fmb-2023-0133","url":null,"abstract":"<p><p><b>Aims:</b> To investigate the effects of Ferrostatin-1 (Fer-1) on improving the prognosis of liver transplant recipients with steatotic liver grafts and regulating gut microbiota in rats. <b>Methods:</b> We obtained steatotic liver grafts and established a liver transplantation model. Recipients were divided into sham, liver transplantation and Fer-1 treatment groups, which were assessed 1 and 7 days after surgery (n = 6). <b>Results & conclusion:</b> Fer-1 promotes recovery of the histological structure and function of steatotic liver grafts and the intestinal tract, and improves inflammatory responses of recipients following liver transplantation. Fer-1 reduces gut microbiota pathogenicity, and lowers iron absorption and improves fat metabolism of recipients, thereby protecting steatotic liver grafts.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"413-429"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: This study aimed to understand the current level of linezolid (LNZ) resistance in Streptococcus pneumoniae isolates reported over the past 10 years. Material & methods: An electronic search was conducted for the following keywords: ((Streptococcus pneumoniae [title/abstract]) OR (Pneumococcus [title/abstract]) OR (Pneumococci [title/abstract]) AND (linezolid [title/abstract]) OR (Zyvox [title/abstract])) OR (Zyvoxid [title/abstract])). Result: Out of all the studies, 80 had a cross-sectional design, while 11 followed a cohort approach. The prevalence of LNZ resistance among S. pneumoniae isolates ranged from 0% to 4.86%. Discussion: Urgent, high-powered, randomized, controlled trials with participants from endemic regions are needed to gain a comprehensive understanding of the impact on and significance of LNZ treatment to patients.
{"title":"Prevalence of linezolid resistance in <i>Streptococcus pneumoniae</i> isolates: a systematic review and meta-analysis.","authors":"Mohsen Heidary, Shirin Dashtbin, Arezoo Asadi, Parisa Asadollahi, Ali Khatib, Mohammad Amin Ebrahimi, Zahra Ghanbari, Atieh Darbandi, Roya Ghanavati, Reza Pakzad","doi":"10.2217/fmb-2023-0170","DOIUrl":"10.2217/fmb-2023-0170","url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to understand the current level of linezolid (LNZ) resistance in <i>Streptococcus pneumoniae</i> isolates reported over the past 10 years. <b>Material & methods:</b> An electronic search was conducted for the following keywords: ((<i>Streptococcus pneumoniae</i> [title/abstract]) OR (<i>Pneumococcus</i> [title/abstract]) OR (Pneumococci [title/abstract]) AND (linezolid [title/abstract]) OR (Zyvox [title/abstract])) OR (Zyvoxid [title/abstract])). <b>Result:</b> Out of all the studies, 80 had a cross-sectional design, while 11 followed a cohort approach. The prevalence of LNZ resistance among <i>S. pneumoniae</i> isolates ranged from 0% to 4.86%. <b>Discussion:</b> Urgent, high-powered, randomized, controlled trials with participants from endemic regions are needed to gain a comprehensive understanding of the impact on and significance of LNZ treatment to patients.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"449-459"},"PeriodicalIF":2.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140143132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-03-12DOI: 10.2217/fmb-2022-0265
Heike Ef Becker, Nader Kameli, Alice Rustichelli, Britt Am Heijnens, Frank Rm Stassen, John Penders, Daisy Mae Jonkers
Aim: This study aimed to examine the impact of fecal water (FW) of active and remissive Crohn's disease (CD) patients on mucin degradation and epithelial barrier function. Methods: FW and bacterial membrane vesicles (MVs) were isolated from fresh fecal samples of six healthy controls (HCs) and 12 CD patients. Bacterial composition was determined by 16S rRNA gene amplicon sequencing. Results:In vitro FW-induced mucin degradation was higher in CD samples versus HC (p < 0.01), but not associated with specific bacterial genera. FW of three remissive samples decreased transepithelial electrical resistance in Caco-2 cells by 78-87% (p < 0.001). MVs did not induce barrier alterations. Conclusion: The higher mucin-degradation capacity of CD-derived FW might suggest contributions of microbial products to CD pathophysiology.
目的:本研究旨在探讨活动期和缓解期克罗恩病(CD)患者的粪便水(FW)对粘蛋白降解和上皮屏障功能的影响。研究方法从 6 名健康对照组(HCs)和 12 名克罗恩病患者的新鲜粪便样本中分离出粪便水和细菌膜囊(MVs)。通过 16S rRNA 基因扩增片段测序确定细菌组成。结果体外 FW 诱导的粘蛋白降解率在 CD 样本中高于 HC 样本(p 结论:体外 FW 诱导的粘蛋白降解率在 CD 样本中高于 HC 样本:CD 来源的 FW 具有更高的粘蛋白降解能力,这可能表明微生物产物对 CD 的病理生理学有贡献。
{"title":"<i>In vitro</i> mucin degradation and paracellular permeability by fecal water from Crohn's disease patients.","authors":"Heike Ef Becker, Nader Kameli, Alice Rustichelli, Britt Am Heijnens, Frank Rm Stassen, John Penders, Daisy Mae Jonkers","doi":"10.2217/fmb-2022-0265","DOIUrl":"10.2217/fmb-2022-0265","url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to examine the impact of fecal water (FW) of active and remissive Crohn's disease (CD) patients on mucin degradation and epithelial barrier function. <b>Methods:</b> FW and bacterial membrane vesicles (MVs) were isolated from fresh fecal samples of six healthy controls (HCs) and 12 CD patients. Bacterial composition was determined by 16S rRNA gene amplicon sequencing. <b>Results:</b> <i>In vitro</i> FW-induced mucin degradation was higher in CD samples versus HC (p < 0.01), but not associated with specific bacterial genera. FW of three remissive samples decreased transepithelial electrical resistance in Caco-2 cells by 78-87% (p < 0.001). MVs did not induce barrier alterations. <b>Conclusion:</b> The higher mucin-degradation capacity of CD-derived FW might suggest contributions of microbial products to CD pathophysiology.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"335-347"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140101441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-02-15DOI: 10.2217/fmb-2023-0029
Xian Wu, Liying Sun, Lei Huang, Chenwei Huang, Kuixia Sun, Haixia Li
Background: The interaction between the host and Candida albicans is dynamic and intricate. We performed proteomic analysis to explore monocyte-C. albicans hyphae interaction. Materials & methods: Primary human monocytes were stimulated by heat-killed C. albicans hyphae and their proteins were profiled by tandem liquid chromatography with mass spectrometry (LC-MS/MS). Results: Based on the protein database of different species for analysis, we found that stimulation of monocytes by hyphae was accompanied by upregulation of histones and activation of extracellular traps (ETs) formation pathway. Meanwhile, monocyte ETs (MoETs) were evoked by synthesis or alteration of C. albicans cell wall proteins expression during the morphological switch to hyphal. Conclusion: MoETs formation is linked to cell wall proteins of C. albicans hyphae.
{"title":"Proteomic alterations associated with the formation of monocyte extracellular trap induced by <i>Candida albicans</i> hyphae.","authors":"Xian Wu, Liying Sun, Lei Huang, Chenwei Huang, Kuixia Sun, Haixia Li","doi":"10.2217/fmb-2023-0029","DOIUrl":"10.2217/fmb-2023-0029","url":null,"abstract":"<p><p><b>Background:</b> The interaction between the host and <i>Candida albicans</i> is dynamic and intricate. We performed proteomic analysis to explore monocyte<i>-C. albicans</i> hyphae interaction. <b>Materials & methods:</b> Primary human monocytes were stimulated by heat-killed <i>C. albicans</i> hyphae and their proteins were profiled by tandem liquid chromatography with mass spectrometry (LC-MS/MS). <b>Results:</b> Based on the protein database of different species for analysis, we found that stimulation of monocytes by hyphae was accompanied by upregulation of histones and activation of extracellular traps (ETs) formation pathway. Meanwhile, monocyte ETs (MoETs) were evoked by synthesis or alteration of <i>C. albicans</i> cell wall proteins expression during the morphological switch to hyphal. <b>Conclusion:</b> MoETs formation is linked to cell wall proteins of <i>C. albicans</i> hyphae.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"307-316"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139734946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-02-02DOI: 10.2217/fmb-2023-0138
Taher Azimi, Sina Nasrollahian, Sahar Sabour, Nahal Hadi, Leila Azimi, Fatemeh Fallah, Mohammed Reza Pourmand
Background: The present study aims to determine the presence of Yersinia spp., Yersinia pestis, Yersinia enterocolitica pathogen, Listeria monocytogenes, Salmonella spp., Shigella spp., Francisella tularensis and Borrelia spp. in brown rats of Tehran, Iran. Methods: PCR was used to detect various bacteria in 100 brown rats, Also, ELISA was used to detect antibodies against the F. tularensis and Borrelia spp. Results: A total of 16% and 13% of fecal samples were positive for Yersinia spp. and Y. enterocolitica pathogen. ELISA results were negative for F. tularensis and Borrelia. No specific antibodies (IgG) were against these bacteria. Conclusion: According to the results of our analysis, rats are significant transmitters and carriers of a variety of illnesses that can spread to both people and other animals.
{"title":"Detection of <i>Yersinia enterocolitica</i>, <i>Shigella</i> spp. and <i>Salmonella</i> spp. in <i>Rattus norvegicus</i> captured from Tehran, Iran.","authors":"Taher Azimi, Sina Nasrollahian, Sahar Sabour, Nahal Hadi, Leila Azimi, Fatemeh Fallah, Mohammed Reza Pourmand","doi":"10.2217/fmb-2023-0138","DOIUrl":"10.2217/fmb-2023-0138","url":null,"abstract":"<p><p><b>Background:</b> The present study aims to determine the presence of <i>Yersinia</i> spp., <i>Yersinia pestis</i>, <i>Yersinia enterocolitica</i> pathogen, <i>Listeria monocytogenes</i>, <i>Salmonella</i> spp., <i>Shigella</i> spp., <i>Francisella tularensis</i> and <i>Borrelia</i> spp. in brown rats of Tehran, Iran. <b>Methods:</b> PCR was used to detect various bacteria in 100 brown rats, Also, ELISA was used to detect antibodies against the <i>F. tularensis</i> and <i>Borrelia</i> spp. <b>Results:</b> A total of 16% and 13% of fecal samples were positive for <i>Yersinia</i> spp. and <i>Y. enterocolitica</i> pathogen. ELISA results were negative for <i>F. tularensis</i> and <i>Borrelia</i>. No specific antibodies (IgG) were against these bacteria. <b>Conclusion:</b> According to the results of our analysis, rats are significant transmitters and carriers of a variety of illnesses that can spread to both people and other animals.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"377-384"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01Epub Date: 2024-02-21DOI: 10.2217/fmb-2023-0212
Rafael M Gandra, Clarissa A Pacheco, Leandro S Sangenito, Lívia S Ramos, Lucieri Op Souza, Pauraic McCarron, Malachy McCann, Michael Devereux, Marta H Branquinha, André Ls Santos
Background: New chemotherapeutics are urgently required to treat Candida infections caused by drug-resistant strains. Methods: The effects of 16 1,10-phenanthroline (phen)/1,10-phenanthroline-5,6-dione/dicarboxylate complexed with Mn(II), Cu(II) and Ag(I) were evaluated against ten different Candida species. Results: Proliferation of Candida albicans, Candida dubliniensis, Candida famata, Candida glabrata, Candida guilliermondii, Candida kefyr, Candida krusei, Candida lusitaniae, Candida parapsilosis and Candida tropicalis was inhibited by three of six Cu(II) (MICs 1.52-21.55 μM), three of three Ag(I) (MICs 0.11-12.74 μM) and seven of seven Mn(II) (MICs 0.40-38.06 μM) complexes. Among these [Mn2(oda)(phen)4(H2O)2][Mn2(oda)(phen)4(oda)2].4H2O, where oda = octanedioic acid, exhibited effective growth inhibition (MICs 0.4-3.25 μM), favorable activity indexes, low toxicity against Vero cells and good/excellent selectivity indexes (46.88-375). Conclusion: [Mn2(oda)(phen)4(H2O)2][Mn2(oda)(phen)4(oda)2].4H2O represents a promising chemotherapeutic option for emerging, medically relevant and drug-resistant Candida species.
{"title":"Manganese(II), copper(II) and silver(I) complexes containing 1,10-phenanthroline/1,10-phenanthroline-5,6-dione against <i>Candida</i> species.","authors":"Rafael M Gandra, Clarissa A Pacheco, Leandro S Sangenito, Lívia S Ramos, Lucieri Op Souza, Pauraic McCarron, Malachy McCann, Michael Devereux, Marta H Branquinha, André Ls Santos","doi":"10.2217/fmb-2023-0212","DOIUrl":"10.2217/fmb-2023-0212","url":null,"abstract":"<p><p><b>Background:</b> New chemotherapeutics are urgently required to treat <i>Candida</i> infections caused by drug-resistant strains. <b>Methods:</b> The effects of 16 1,10-phenanthroline (phen)/1,10-phenanthroline-5,6-dione/dicarboxylate complexed with Mn(II), Cu(II) and Ag(I) were evaluated against ten different <i>Candida</i> species. <b>Results:</b> Proliferation of <i>Candida albicans</i>, <i>Candida dubliniensis</i>, <i>Candida famata</i>, <i>Candida glabrata</i>, <i>Candida guilliermondii</i>, <i>Candida kefyr</i>, <i>Candida krusei</i>, <i>Candida lusitaniae</i>, <i>Candida parapsilosis</i> and <i>Candida tropicalis</i> was inhibited by three of six Cu(II) (MICs 1.52-21.55 μM), three of three Ag(I) (MICs 0.11-12.74 μM) and seven of seven Mn(II) (MICs 0.40-38.06 μM) complexes. Among these [Mn<sub>2</sub>(oda)(phen)<sub>4</sub>(H<sub>2</sub>O)<sub>2</sub>][Mn<sub>2</sub>(oda)(phen)<sub>4</sub>(oda)<sub>2</sub>].4H<sub>2</sub>O, where oda = octanedioic acid, exhibited effective growth inhibition (MICs 0.4-3.25 μM), favorable activity indexes, low toxicity against Vero cells and good/excellent selectivity indexes (46.88-375). <b>Conclusion:</b> [Mn<sub>2</sub>(oda)(phen)<sub>4</sub>(H<sub>2</sub>O)<sub>2</sub>][Mn<sub>2</sub>(oda)(phen)<sub>4</sub>(oda)<sub>2</sub>].4H<sub>2</sub>O represents a promising chemotherapeutic option for emerging, medically relevant and drug-resistant <i>Candida</i> species.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"385-395"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139912423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}